Las Vegas is a beacon of hopes and dreams in the middle of a desert – perhaps an analogy for the enduring work of the NF2 scientific and clinical communities in seeking treatments and better management strategies for a confounding condition. The good news is, the bets that are being placed on candidate approaches for NF2 treatment are becoming progresively more focussed and more informed as we understand more about the molecular biology and natural history of NF2. Yesterday evening as meeting delegates filtered in to register, I heard a few snapshots about clinical trial updates and new information on implantable devices that confirmed this should make this an exciting and broad reaching meeting. Ironically Bally’s, the NF2 meeting location, is right next door to the Paris casino, and it was in Paris, France that the NF2 community met for this same meeting series in 2006. And just as that Paris meeting spurred a variety of NF2 collaborations and advancements, we hope that the adage ‘what happens in Vegas stays in Vegas’ will not apply to the new ideas and concepts that are bound emerge over the next few days.
Stay tuned!
NF2: Las Vegas Meeting Preview
